What the FDA labels say about taking them together
Betiatide and sodium pyrophosphate/stannous
Sodium pyrophosphate/stannous's FDA label of December 5, 2025 names betiatide in its warnings section; the betiatide labels PlainMeds reads (2) do not name sodium pyrophosphate/stannous. The sodium pyrophosphate/stannous label: “Avoid heparinized catheter systems for administration of Technescan PYP.”
Check it at the source: the betiatide FDA label on DailyMed (effective January 6, 2026); the sodium pyrophosphate/stannous FDA label on DailyMed (effective December 5, 2025).
What does the betiatide label say about sodium pyrophosphate/stannous?
Betiatide's label (effective January 6, 2026) and its 1 other brand-application label do not name sodium pyrophosphate/stannous in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Technescan MAG3), Curium US LLC, effective January 6, 2026 (SPL set 0571c18b-1d5e-47bd-bddf-54d74ce1b442), via openFDA; the full label on DailyMed
What does the sodium pyrophosphate/stannous label say about betiatide?
Sodium pyrophosphate/stannous label, warningsAvoid heparinized catheter systems for administration of Technescan PYP.
Source: FDA drug label (Technescan PYP), Curium US LLC, effective December 5, 2025 (SPL set 304b63f4-a32e-4700-805d-5bc9f27e7d6a), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Betiatide | Sodium pyrophosphate/stannous | |
|---|---|---|
| Labeled for | n/a | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | In shortage |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once